MyoKardia (NASDAQ: MYOK) reported Q1 EPS of ($0.37), $0.06 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $5.6 million versus the consensus estimate of $6.31 million.

For earnings history and earnings-related data on MyoKardia (MYOK) click here.